Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many of Australia's top brokers have been busy adjusting their financial models again. This has led to the release of a number of broker notes this week.

Three ASX shares that brokers have named as buys this week are listed below. Here's why they are feeling bullish on them right now:

Hub24 Ltd (ASX: HUB)

According to a note out of Morgan Stanley, its analysts have retained their overweight rating and $44.00 price target on this investment platform provider's shares. This follows the release of the company's third-quarter update this week. Morgan Stanley highlights that the company's platform funds under administration (FUA) of $79.7 billion came in ahead of its estimates. In light of this and higher seasonal flows, the broker sees scope for the company to outperform in the fourth quarter. The broker was also pleased to see management reaffirm its guidance for platform FUA to reach $92 billion to 100 billion in FY 2025. The HUB24 share price is trading at $39.62 this afternoon.

Pro Medicus Limited (ASX: PME)

A note out of Goldman Sachs reveals that its analysts have initiated coverage on this health imaging company's shares with a buy rating and $134.00 price target. The broker sees Pro Medicus as the clear incumbent technology leader in a growing market with a strong financial profile and significant artificial intelligence upside. Goldman believes that the company's Visage 7 platform is core to many healthcare institutions, providing efficiency gains in a market where demand for imaging continues to grow and radiologist shortages persist. It thinks it can increase its US market share to 13% in FY 2030 from ~7% today. The Pro Medicus share price is fetching $101.94 on Wednesday.

Zip Co Ltd (ASX: ZIP)

Analysts at UBS have retained their buy rating on this buy now pay later provider's shares with an improved price target of $1.55. This follows the release of the company's third-quarter update this week which revealed a 14.6% increase in total transaction volume and a 26.6% jump in revenue. UBS was pleased with the stronger-than-expected update. It notes that it was driven by a particularly strong performance from its Zip Americas business. And while it was slightly disappointed with the performance of the Zip AU business, it believes this will stabilise in FY 2025 and then return to growth. Overall, the broker was impressed and its earnings estimates have been revised higher. The Zip share price is trading at $1.14 on Wednesday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Hub24, Pro Medicus, and Zip Co. The Motley Fool Australia has recommended Hub24 and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
Broker Notes

Morgans says these ASX stocks can rise 20% (and pay big dividends!)

The broker believes some very big returns could be on the cards over the next 12 months.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

happy investor, share price rise, increase, up
Broker Notes

These ASX 200 shares could rise 15% to 50%

Analysts think these shares can rise strongly from where they trade today.

Read more »

a man peers through a broken brick wall to see grey clouds gathering beyond it
Share Market News

Why this smashed ASX 200 share is a fundie's top value pick

It's an ASX consumer discretionary stock that has lost 40% of its value over the past year.

Read more »

Happy man working on his laptop.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Resources Shares

Up 51% from their 52-week low, is it too late to buy Mineral Resources shares?

Mineral Resources has been on a tear since mid-January. Do these top brokers think it's too late to buy?

Read more »

A laughing woman pushes her friend, who has her arms outstretched, in a supermarket trolley.
Retail Shares

Goldman says these 6 ASX retail shares are a buying opportunity

The latest retail trading data was historically weak, according to the Australian Bureau of Statistics.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Buy, hold or sell these 3 ASX 200 healthcare shares: Experts

These experts reveal their calls on CSL, Resmed and Sonic Healthcare shares today.

Read more »